These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E; Schnell O Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
3. Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes. Jawa AA; Fonseca VA Cardiol Clin; 2005 May; 23(2):119-38. PubMed ID: 15694742 [TBL] [Abstract][Full Text] [Related]
4. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes. Bianchi C; Miccoli R; Daniele G; Penno G; Del Prato S Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S342-8. PubMed ID: 19875578 [No Abstract] [Full Text] [Related]
5. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes]. Hemmingsen B; Lund SS; Vaag A Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642 [TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus. Medication update. Slagle M South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245 [No Abstract] [Full Text] [Related]
8. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease. Saha SA; Tuttle KR Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253 [TBL] [Abstract][Full Text] [Related]
15. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity]. Simonin R Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845 [No Abstract] [Full Text] [Related]
16. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)]. Masbernard A; Portal A Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526 [No Abstract] [Full Text] [Related]
17. Cardiovascular effects of insulin sensitizers in diabetes. Jawa A; Fonseca V Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258 [TBL] [Abstract][Full Text] [Related]
18. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Johnson JA; Majumdar SR Am Heart J; 2004 Dec; 148(6):e27; author reply e28. PubMed ID: 15632864 [No Abstract] [Full Text] [Related]
19. Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction. Leo CH; Woodman OL J Cardiovasc Pharmacol; 2015 Jun; 65(6):532-44. PubMed ID: 25387248 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes. Home P Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S33-42. PubMed ID: 22650223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]